All articles tagged with #ptp1b
Blocking the protein PTP1B improved learning and memory in a mouse model of Alzheimer's by boosting microglial clearance of amyloid-β plaques through enhanced SYK signaling; because PTP1B is also tied to obesity and diabetes, this approach could address multiple disease pathways and be combined with existing Alzheimer's treatments, with DepYmed, Inc. collaborating to develop the inhibitors.
Researchers at Cold Spring Harbor Laboratory found that inhibiting the enzyme PTP1B improves brain microglial function and helps clear amyloid-β plaques in mice, potentially slowing memory decline in Alzheimer's disease. The study suggests PTP1B inhibitors could be paired with existing therapies, with ongoing work to develop such inhibitors for clinical use.
In a mouse model of Alzheimer’s disease, researchers found that inhibiting the brain enzyme PTP1B enhances microglial clearance of amyloid-beta by boosting SYK signaling, improving learning and memory. Because PTP1B is already a target for metabolic disorders, this approach could complement existing amyloid-clearing therapies and pave the way for combination treatments to slow disease progression.